Corrective and Preventive Actions, Completion of an Audit, Audit Certificate
8 Corrective and Preventive Actions
Implementation of a CAPA plan after the conduct of an audit is necessary to eliminate present and potential causes of non-conformity and prevent re-occurrence or future occurrence. Once the conduct of the audit is complete the auditor should be provided a CAPA plan to the auditee that will be utilized to remediate issues of non-compliance and potential non-compliance identified during the audit process. The CAPA plan should, at minimum, require the auditee to identify the root-cause of audit findings and describe whether corrective and/or preventive actions will be necessary to address the audit findings.
9 Completion of an Audit
Upon receipt of the preliminary responses to the CAPA from the auditee, the audit is completed. Follow-up should be performed depending on the significance of the audit findings. CAPA follow-up and subsequent effectiveness verification should be ensured by continued interaction between the auditor and auditee until mutual agreement has been met that the CAPA have been addressed.
10 Audit Certificate
The auditor (including the auditing department manager) should prepare an audit certificate at the request of the sponsor. The sponsor should attach the audit certificate to a clinical trial/study report of the targeted trial. The audit certificate should contain the following information: • Information that identifies the trial, such as the chemical name or identification code of the investigational drug, the trial title, and the protocol number. • The date of issuing the audit certificate. • The contents of the audit (e.g., subjects and date of the audit, and date of issuing the audit report). • The name(s), title and address of the auditor (s)(and the auditing department manager). • The name and workplace address of the auditee.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
17 – 19 April 2024SCDM (Society of Clinical Data Management)Poland
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Připravované klinické studie
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Zatím nenabírámeKolorektální karcinomSpojené státy
-
Hull University Teaching Hospitals NHS TrustNáborChronický kašelSpojené království
-
University of Roma La SapienzaNábor
-
The Second Hospital of Nanjing Medical UniversitySIR RUN RUN hospital of Nanjing Medical UniversityZatím nenabírámePorucha pozornosti/hyperaktivitaČína
-
Parnassia GroepNáborPoruchou autistického spektraHolandsko
-
Dickran Kazandjian, MDRegeneron PharmaceuticalsZatím nenabíráme
-
Ray Therapeutics, Inc.The Vision Research and Assessment Institute (VRAI)NáborRetinitis PigmentosaSpojené státy
-
Istituto Ortopedico RizzoliZatím nenabírámeRehabilitace | Kostní novotvar
-
University of Missouri-ColumbiaGilead SciencesNáborHIV infekce | UMĚNÍ | Nedodržení, pacienteSpojené státy
-
Florida International UniversityAnn & Robert H Lurie Children's Hospital of Chicago; Care Resource Community...Zatím nenabírámeART AdherenceSpojené státy
-
Hebei Medical University Fourth HospitalZatím nenabírámeRakovina, související s terapií
-
Peking Union Medical College HospitalZatím nenabíráme